Published in Mar Drugs on May 27, 2014
Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations. Proc Natl Acad Sci U S A (2017) 0.75
The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev (2000) 11.65
Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 9.09
The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest (1998) 4.76
Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem (2006) 2.04
Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. J Mol Biol (2003) 1.57
Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites. Mol Pharmacol (2007) 1.39
Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation. J Pharmacol Exp Ther (2010) 1.31
Sterol content of foods of plant origin. J Am Diet Assoc (1978) 1.30
Rifaximin is a gut-specific human pregnane X receptor activator. J Pharmacol Exp Ther (2007) 1.26
Solomonsterols A and B from Theonella swinhoei. The first example of C-24 and C-23 sulfated sterols from a marine source endowed with a PXR agonistic activity. J Med Chem (2010) 1.18
Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. J Med Chem (2011) 1.09
Plasma concentrations of plant sterols: physiology and relationship with coronary heart disease. Nutr Rev (2006) 1.08
Synthetic drugs and natural products as modulators of constitutive androstane receptor (CAR) and pregnane X receptor (PXR). Drug Metab Rev (2006) 1.06
Theonellasterols and conicasterols from Theonella swinhoei. Novel marine natural ligands for human nuclear receptors. J Med Chem (2011) 1.04
Chrysin ameliorates chemically induced colitis in the mouse through modulation of a PXR/NF-κB signaling pathway. J Pharmacol Exp Ther (2013) 1.02
Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells. Eur J Pharmacol (2011) 1.01
Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors. Mol Pharm (2006) 0.99
Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol Sci (2012) 0.99
Towards new ligands of nuclear receptors. Discovery of malaitasterol A, an unique bis-secosterol from marine sponge Theonella swinhoei. Org Biomol Chem (2011) 0.95
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. PLoS One (2012) 0.95
Development of FXR, PXR and CAR agonists and antagonists for treatment of liver disorders. Curr Top Med Chem (2012) 0.93
Conicasterol E, a small heterodimer partner sparing farnesoid X receptor modulator endowed with a pregnane X receptor agonistic activity, from the marine sponge Theonella swinhoei. J Med Chem (2011) 0.91
Marine sponge steroids as nuclear receptor ligands. Trends Pharmacol Sci (2012) 0.90
The structure and absolute configuration of the marine sterol gorgosterol. J Am Chem Soc (1970) 0.87
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. Steroids (2012) 0.87
Plakilactones from the marine sponge Plakinastrella mamillaris. Discovery of a new class of marine ligands of peroxisome proliferator-activated receptor γ. J Med Chem (2012) 0.86
Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. Design, synthesis, and biological evaluation of novel ligands. J Med Chem (2013) 0.85
Antidiabetic activity of passive nonsteroidal glucocorticoid receptor modulators. J Med Chem (2005) 0.85
Oxygenated polyketides from Plakinastrella mamillaris as a new chemotype of PXR agonists. Mar Drugs (2013) 0.85
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. J Med Chem (2014) 0.84
Modification in the side chain of solomonsterol A: discovery of cholestan disulfate as a potent pregnane-X-receptor agonist. Org Biomol Chem (2012) 0.83
Natural ligands for nuclear receptors: biology and potential therapeutic applications. Curr Top Med Chem (2012) 0.82
The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: implications for the development of dissociated antiprogestins. Endocrinology (1999) 0.81
5 Alpha-cholest-8(14)-en-3 beta-ol, a possible intermediate in the biosynthesis of cholesterol. Enzymatic conversion to cholesterol and isolation from rat skin. J Biol Chem (1969) 0.81
Therapeutic potential of plant sterols and stanols. Curr Opin Lipidol (2000) 0.81
Identification of three novel natural product compounds that activate PXR and CAR and inhibit inflammation. Pharm Res (2013) 0.79
Insights on pregnane-X-receptor modulation. Natural and semisynthetic steroids from Theonella marine sponges. Eur J Med Chem (2013) 0.79
Potential bile acid metabolites. 13. Improved routes to 3 beta, 6 beta- and 3 beta, 6 alpha-dihydroxy-5 beta-cholanoic acids. J Lipid Res (1988) 0.77
Incisterols, highly degraded marine sterols, are a new chemotype of PXR agonists. Steroids (2014) 0.76